<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Tue, 02 Jun 2026 07:01:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Aldeyra Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference</title>
   <link>http://www.streetinsider.com/Press+Releases/Aldeyra+Therapeutics+to+Participate+in+the+2026+Jefferies+Global+Healthcare+Conference/26587226.html</link>
   <description>
&lt;p&gt;    LEXINGTON, Mass.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.aldeyra.com&amp;amp;esheet=54545618&amp;amp;newsitemid=20260602792258&amp;amp;lan=en-US&amp;amp;anchor=Aldeyra+Therapeutics%2C+Inc.&amp;amp;index=1&amp;amp;md5=45a228c74c399885d4c8fd0b667fd6d6&quot; shape=&quot;rect&quot;&gt;Aldeyra Therapeutics, Inc.&lt;/a&gt; (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference in New York, New York.

&lt;/p&gt;&lt;p&gt;
Dr. Brady’s conversation with Amin Makarem, Vice President, Biotechnology Equity Research at Jefferies, is scheduled to begin at 8:45 a.m. ET Thursday, June 4, 2026. To view the live webcast, log in to the Investors &amp;amp; Media section of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Aldeyra+Therapeutics+to+Participate+in+the+2026+Jefferies+Global+Healthcare+Conference/26587226.html</guid>
   <pubDate>Tue, 02 Jun 2026 07:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Aldeyra Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference</title>
   <link>http://www.streetinsider.com/Press+Releases/Aldeyra+Therapeutics+to+Participate+in+the+2026+Jefferies+Global+Healthcare+Conference/26587226.html</link>
   <description>
&lt;p&gt;    LEXINGTON, Mass.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.aldeyra.com&amp;amp;esheet=54545618&amp;amp;newsitemid=20260602792258&amp;amp;lan=en-US&amp;amp;anchor=Aldeyra+Therapeutics%2C+Inc.&amp;amp;index=1&amp;amp;md5=45a228c74c399885d4c8fd0b667fd6d6&quot; shape=&quot;rect&quot;&gt;Aldeyra Therapeutics, Inc.&lt;/a&gt; (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference in New York, New York.

&lt;/p&gt;&lt;p&gt;
Dr. Brady’s conversation with Amin Makarem, Vice President, Biotechnology Equity Research at Jefferies, is scheduled to begin at 8:45 a.m. ET Thursday, June 4, 2026. To view the live webcast, log in to the Investors &amp;amp; Media section of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Aldeyra+Therapeutics+to+Participate+in+the+2026+Jefferies+Global+Healthcare+Conference/26587226.html</guid>
   <pubDate>Tue, 02 Jun 2026 07:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Aldeyra Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference</title>
   <link>http://www.streetinsider.com/Business+Wire/Aldeyra+Therapeutics+to+Participate+in+the+2026+Jefferies+Global+Healthcare+Conference/26587226.html</link>
   <description>
&lt;p&gt;    LEXINGTON, Mass.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.aldeyra.com&amp;amp;esheet=54545618&amp;amp;newsitemid=20260602792258&amp;amp;lan=en-US&amp;amp;anchor=Aldeyra+Therapeutics%2C+Inc.&amp;amp;index=1&amp;amp;md5=45a228c74c399885d4c8fd0b667fd6d6&quot; shape=&quot;rect&quot;&gt;Aldeyra Therapeutics, Inc.&lt;/a&gt; (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference in New York, New York.

&lt;/p&gt;&lt;p&gt;
Dr. Brady’s conversation with Amin Makarem, Vice President, Biotechnology Equity Research at Jefferies, is scheduled to begin at 8:45 a.m. ET Thursday, June 4, 2026. To view the live webcast, log in to the Investors &amp;amp; Media section of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Aldeyra+Therapeutics+to+Participate+in+the+2026+Jefferies+Global+Healthcare+Conference/26587226.html</guid>
   <pubDate>Tue, 02 Jun 2026 07:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Aldeyra Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference</title>
   <link>http://www.streetinsider.com/Business+Wire/Aldeyra+Therapeutics+to+Participate+in+the+2026+Jefferies+Global+Healthcare+Conference/26587226.html</link>
   <description>
&lt;p&gt;    LEXINGTON, Mass.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.aldeyra.com&amp;amp;esheet=54545618&amp;amp;newsitemid=20260602792258&amp;amp;lan=en-US&amp;amp;anchor=Aldeyra+Therapeutics%2C+Inc.&amp;amp;index=1&amp;amp;md5=45a228c74c399885d4c8fd0b667fd6d6&quot; shape=&quot;rect&quot;&gt;Aldeyra Therapeutics, Inc.&lt;/a&gt; (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference in New York, New York.

&lt;/p&gt;&lt;p&gt;
Dr. Brady’s conversation with Amin Makarem, Vice President, Biotechnology Equity Research at Jefferies, is scheduled to begin at 8:45 a.m. ET Thursday, June 4, 2026. To view the live webcast, log in to the Investors &amp;amp; Media section of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Aldeyra+Therapeutics+to+Participate+in+the+2026+Jefferies+Global+Healthcare+Conference/26587226.html</guid>
   <pubDate>Tue, 02 Jun 2026 07:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G/A  Aldeyra Therapeutics,                  Filed by: PERCEPTIVE ADVISORS LLC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Aldeyra+Therapeutics%2C++++++++++++++++++Filed+by%3A+PERCEPTIVE+ADVISORS+LLC/26504583.html</link>
   <description>si-local-file:///var/storage/secattach/20260515/26504583.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Aldeyra+Therapeutics%2C++++++++++++++++++Filed+by%3A+PERCEPTIVE+ADVISORS+LLC/26504583.html</guid>
   <pubDate>Fri, 15 May 2026 16:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G/A  Aldeyra Therapeutics,                  Filed by: PERCEPTIVE ADVISORS LLC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Aldeyra+Therapeutics%2C++++++++++++++++++Filed+by%3A+PERCEPTIVE+ADVISORS+LLC/26504583.html</link>
   <description>si-local-file:///var/storage/secattach/20260515/26504583.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Aldeyra+Therapeutics%2C++++++++++++++++++Filed+by%3A+PERCEPTIVE+ADVISORS+LLC/26504583.html</guid>
   <pubDate>Fri, 15 May 2026 16:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  10-Q       Aldeyra Therapeutics,     For: Mar 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Aldeyra+Therapeutics%2C+++++For%3A+Mar+31/26452711.html</link>
   <description>si-local-file:///var/storage/secattach/20260507/26452711.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Aldeyra+Therapeutics%2C+++++For%3A+Mar+31/26452711.html</guid>
   <pubDate>Thu, 07 May 2026 16:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  10-Q       Aldeyra Therapeutics,     For: Mar 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Aldeyra+Therapeutics%2C+++++For%3A+Mar+31/26452711.html</link>
   <description>si-local-file:///var/storage/secattach/20260507/26452711.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Aldeyra+Therapeutics%2C+++++For%3A+Mar+31/26452711.html</guid>
   <pubDate>Thu, 07 May 2026 16:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  8-K        Aldeyra Therapeutics,     For: May 01</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Aldeyra+Therapeutics%2C+++++For%3A+May+01/26415297.html</link>
   <description>si-local-file:///var/storage/secattach/20260501/26415297.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Aldeyra+Therapeutics%2C+++++For%3A+May+01/26415297.html</guid>
   <pubDate>Fri, 01 May 2026 11:52:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  8-K        Aldeyra Therapeutics,     For: May 01</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Aldeyra+Therapeutics%2C+++++For%3A+May+01/26415297.html</link>
   <description>si-local-file:///var/storage/secattach/20260501/26415297.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Aldeyra+Therapeutics%2C+++++For%3A+May+01/26415297.html</guid>
   <pubDate>Fri, 01 May 2026 11:52:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  ARS        Aldeyra Therapeutics,     For: Dec 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++ARS++++++++Aldeyra+Therapeutics%2C+++++For%3A+Dec+31/26375087.html</link>
   <description>si-local-file:///var/storage/secattach/20260427/26375087.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++ARS++++++++Aldeyra+Therapeutics%2C+++++For%3A+Dec+31/26375087.html</guid>
   <pubDate>Mon, 27 Apr 2026 16:17:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  ARS        Aldeyra Therapeutics,     For: Dec 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++ARS++++++++Aldeyra+Therapeutics%2C+++++For%3A+Dec+31/26375087.html</link>
   <description>si-local-file:///var/storage/secattach/20260427/26375087.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++ARS++++++++Aldeyra+Therapeutics%2C+++++For%3A+Dec+31/26375087.html</guid>
   <pubDate>Mon, 27 Apr 2026 16:17:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  DEFA14A    Aldeyra Therapeutics,                </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Aldeyra+Therapeutics%2C++++++++++++++++/26375032.html</link>
   <description>si-local-file:///var/storage/secattach/20260427/26375032.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Aldeyra+Therapeutics%2C++++++++++++++++/26375032.html</guid>
   <pubDate>Mon, 27 Apr 2026 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  DEFA14A    Aldeyra Therapeutics,                </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Aldeyra+Therapeutics%2C++++++++++++++++/26375032.html</link>
   <description>si-local-file:///var/storage/secattach/20260427/26375032.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Aldeyra+Therapeutics%2C++++++++++++++++/26375032.html</guid>
   <pubDate>Mon, 27 Apr 2026 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  DEF 14A    Aldeyra Therapeutics,     For: Jun 10</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++DEF+14A++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+10/26374808.html</link>
   <description>si-local-file:///var/storage/secattach/20260427/26374808.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++DEF+14A++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+10/26374808.html</guid>
   <pubDate>Mon, 27 Apr 2026 16:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  DEF 14A    Aldeyra Therapeutics,     For: Jun 10</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++DEF+14A++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+10/26374808.html</link>
   <description>si-local-file:///var/storage/secattach/20260427/26374808.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++DEF+14A++++Aldeyra+Therapeutics%2C+++++For%3A+Jun+10/26374808.html</guid>
   <pubDate>Mon, 27 Apr 2026 16:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  8-K        Aldeyra Therapeutics,     For: Apr 20</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Aldeyra+Therapeutics%2C+++++For%3A+Apr+20/26337840.html</link>
   <description>si-local-file:///var/storage/secattach/20260420/26337840.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Aldeyra+Therapeutics%2C+++++For%3A+Apr+20/26337840.html</guid>
   <pubDate>Mon, 20 Apr 2026 17:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  8-K        Aldeyra Therapeutics,     For: Apr 20</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Aldeyra+Therapeutics%2C+++++For%3A+Apr+20/26337840.html</link>
   <description>si-local-file:///var/storage/secattach/20260420/26337840.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Aldeyra+Therapeutics%2C+++++For%3A+Apr+20/26337840.html</guid>
   <pubDate>Mon, 20 Apr 2026 17:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  8-K        Aldeyra Therapeutics,     For: Apr 01</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Aldeyra+Therapeutics%2C+++++For%3A+Apr+01/26259612.html</link>
   <description>si-local-file:///var/storage/secattach/20260401/26259612.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Aldeyra+Therapeutics%2C+++++For%3A+Apr+01/26259612.html</guid>
   <pubDate>Wed, 01 Apr 2026 16:25:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  8-K        Aldeyra Therapeutics,     For: Apr 01</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Aldeyra+Therapeutics%2C+++++For%3A+Apr+01/26259612.html</link>
   <description>si-local-file:///var/storage/secattach/20260401/26259612.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Aldeyra+Therapeutics%2C+++++For%3A+Apr+01/26259612.html</guid>
   <pubDate>Wed, 01 Apr 2026 16:25:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  4          Aldeyra Therapeutics,     For: Mar 27  Filed by: Brady Todd C</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Mar+27++Filed+by%3A+Brady+Todd+C/26251225.html</link>
   <description>si-local-file:///var/storage/secattach/20260331/26251225.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Mar+27++Filed+by%3A+Brady+Todd+C/26251225.html</guid>
   <pubDate>Tue, 31 Mar 2026 16:18:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  4          Aldeyra Therapeutics,     For: Mar 27  Filed by: Brady Todd C</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Mar+27++Filed+by%3A+Brady+Todd+C/26251225.html</link>
   <description>si-local-file:///var/storage/secattach/20260331/26251225.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Mar+27++Filed+by%3A+Brady+Todd+C/26251225.html</guid>
   <pubDate>Tue, 31 Mar 2026 16:18:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G/A  Aldeyra Therapeutics,                  Filed by: VANGUARD GROUP INC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Aldeyra+Therapeutics%2C++++++++++++++++++Filed+by%3A+VANGUARD+GROUP+INC/26223832.html</link>
   <description>si-local-file:///var/storage/secattach/20260326/26223832.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Aldeyra+Therapeutics%2C++++++++++++++++++Filed+by%3A+VANGUARD+GROUP+INC/26223832.html</guid>
   <pubDate>Thu, 26 Mar 2026 15:26:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G/A  Aldeyra Therapeutics,                  Filed by: VANGUARD GROUP INC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Aldeyra+Therapeutics%2C++++++++++++++++++Filed+by%3A+VANGUARD+GROUP+INC/26223832.html</link>
   <description>si-local-file:///var/storage/secattach/20260326/26223832.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Aldeyra+Therapeutics%2C++++++++++++++++++Filed+by%3A+VANGUARD+GROUP+INC/26223832.html</guid>
   <pubDate>Thu, 26 Mar 2026 15:26:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
  <item>
   <title>Form  4          Aldeyra Therapeutics,     For: Mar 19  Filed by: DOUGLAS RICHARD</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Mar+19++Filed+by%3A+DOUGLAS+RICHARD/26197940.html</link>
   <description>si-local-file:///var/storage/secattach/20260320/26197940.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Aldeyra+Therapeutics%2C+++++For%3A+Mar+19++Filed+by%3A+DOUGLAS+RICHARD/26197940.html</guid>
   <pubDate>Fri, 20 Mar 2026 16:18:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ALDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.08519002</category>
   	  </item>
 </channel>
</rss>
